Arthur Allen

Visit kff.org to read Arthur's bio.

aallen@kff.org
@ArthurAllen202

Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

Why Black and Hispanic Seniors Are Left With a Less Powerful Flu Vaccine

Federal health officials haven’t taken a clear position on whether a high-dose influenza vaccine — on the market since 2010 — is the best choice for people 65 and older. Many in that group already opt for the costlier enhanced shot. Those who get the standard vaccine are disproportionately members of ethnic and racial minorities.

Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.

A corporate CEO’s call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.